These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35849751)

  • 21. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
    Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
    Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database.
    Duquesnoy RJ; Marrari M; Marroquim MS; Borges AG; da Mata Sousa LCD; Socorro A; do Monte SJH
    Hum Immunol; 2019 Feb; 80(2):103-106. PubMed ID: 30458204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
    Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
    Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of the HLA class I eplet database in the website based registry of antibody-defined HLA epitopes.
    Duquesnoy RJ
    Tissue Antigens; 2014 Jun; 83(6):382-90. PubMed ID: 24828055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
    Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
    Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of epitopes on HLA-DRB alleles reacting with antibodies in sera from women sensitized during pregnancy.
    Duquesnoy RJ; Hönger G; Hösli I; Marrari M; Schaub S
    Hum Immunol; 2016 Feb; 77(2):214-22. PubMed ID: 26686763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eplet-Predicted Antigens: An Attempt to Introduce Eplets into Unacceptable Antigen Determination and Calculated Panel-Reactive Antibody Calculation Facilitating Kidney Allocation.
    Wu W; Zhang H; Tan J; Fu Q; Li J; Wu C; Huang H; Xu B; Ling L; Liu L; Su X; Wang C
    Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different luminex single antigen bead kits for memory B cell-derived HLA antibody detection.
    Karahan GE; de Vaal Y; Bakker K; Roelen D; Claas FHJ; Heidt S
    HLA; 2021 Sep; 98(3):200-206. PubMed ID: 34216435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting through the weeds: Evaluation of a novel adsorption with crossmatch cells and elution protocol to sharpen HLA antibody identification by the single antigen bead assay.
    Liwski RS; Tafulo S; Carroll R; Lan JH; Greenshields AL
    Front Genet; 2022; 13():1059650. PubMed ID: 36531234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.
    Schawalder L; Hönger G; Kleiser M; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Schaub S
    HLA; 2021 Jan; 97(1):30-43. PubMed ID: 33068062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-Depth Analysis of Anti-HLA Antibodies Using C1q Assay.
    Zielińska H; Zieliński M; Dębska-Zielkowska J; Dukat-Mazurek A; Moszkowska G; Lewandowska D; Dębska-Ślizień A; Trzonkowski P
    Transplant Proc; 2022 May; 54(4):934-939. PubMed ID: 35534279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM single antigen bead HLA-assay is affected by imlifidase through the cleavage of IgG but not IgM.
    Runström A; Sjöholm K; Roupé KM; Lorant T; Kjellman C; Bockermann R
    Transpl Immunol; 2021 Oct; 68():101436. PubMed ID: 34265468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
    Wen J; Basu A; Bentall A; Henderson N; Dukek B; Gandhi M; Schinstock C
    Hum Immunol; 2021 Apr; 82(4):240-246. PubMed ID: 33618904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The big picture: A case report of antibody mediated rejection and treatment after lung transplantation illustrating the need to correlate laboratory findings with clinical status.
    Zeevi A; Marrari M; Lunz J; Lomago J; Johnson K; Jelinek L; Foster D; Bermudez C; McDyer J; Pilewski J; Ensor C
    Clin Transpl; 2013; ():399-405. PubMed ID: 25095535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.